Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension.
about
Pulmonary arterial hypertension in a patient with β-thalassemia intermedia and reversal with infusion epoprostenol then transition to oral calcium channel blocker therapy: review of literature.Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH).A systematic review of transition studies of pulmonary arterial hypertension specific medicationsTransition from prostacyclin analogue infusion to oral therapy in patients with pulmonary arterial hypertension: a 5-year follow-up.Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.Response to bosentan in children with pulmonary hypertension.Transition from intravenous epoprostenol to oral or subcutaneous therapy in pulmonary arterial hypertension: a retrospective case series and systematic reviewCurrent treatment strategies for pulmonary arterial hypertension.Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.Safety and tolerability of bosentan in the management of pulmonary arterial hypertension.Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension.Bosentan for the treatment of adult pulmonary hypertension.Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension.
P2860
Q33165207-2E682F59-19D8-4A44-89C9-A16268A9AC3FQ33788506-136FB7A1-84D9-44BB-8437-89725E96FCC0Q33788548-6383EC0A-E9E7-4898-BAB8-DD0BEA058AC7Q33806206-3FC54CBF-F9BA-4871-8204-92AE5C999C37Q35110720-4B0A779C-2396-4DB5-B399-7F95CE1160F7Q35771679-78413FC3-2770-42DC-9D53-90C619D1A731Q35895629-1CDD1071-446C-42D9-BE62-18730EEDC337Q36237720-BD98071F-4D7C-4566-A273-EC7350DA7666Q37019838-72BADCE5-3E8F-45C8-AC78-DA56F7A193B9Q37403190-AB84C460-A985-4295-B0C7-0B30E453FC19Q37699659-866E31F8-9134-4C9F-883D-328D4E217D96Q37822722-3636BEFB-2677-4102-9B8B-A68B1C253B19Q45095062-69E27279-9880-4CE5-BC3A-A31DAEFC0FB4
P2860
Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Successful withdrawal of long- ...... lmonary arterial hypertension.
@en
Successful withdrawal of long- ...... lmonary arterial hypertension.
@nl
type
label
Successful withdrawal of long- ...... lmonary arterial hypertension.
@en
Successful withdrawal of long- ...... lmonary arterial hypertension.
@nl
prefLabel
Successful withdrawal of long- ...... lmonary arterial hypertension.
@en
Successful withdrawal of long- ...... lmonary arterial hypertension.
@nl
P2093
P356
P1433
P1476
Successful withdrawal of long- ...... lmonary arterial hypertension.
@en
P2093
Lewis J Rubin
Nick H Kim
Richard N Channick
P304
P356
10.1378/CHEST.124.4.1612
P407
P577
2003-10-01T00:00:00Z